Biomarkers — a silver bullet to cancer diagnosis and treatment, report
21 November, 2017Fast-tracking biomarker research has the potential to transform cancer diagnosis and treatment, according to a report by the University of South Australia's Sansom Institute.
Experts meet to discuss potential of particle therapy for cancer
13 November, 2017Medical and health experts from across Australia and New Zealand recently convened in Adelaide to discuss the way forward for particle therapy in Australia.
Zero Childhood Cancer program comes to WA
10 November, 2017The Zero Childhood Cancer program — said to be one of the world's most comprehensive child cancer personalised medicine studies — has finally reached Western Australia, seven weeks after its national launch.
Award-winning wearable sensor technologies could transform personalised medicine
06 November, 2017ANU has announced the winner of its inaugural Grand Challenge Scheme — a $50 million initiative to provide funding for transformative research with the potential to radically change our understanding of, and responses to, the world's most intractable problems.
Acid reflux drugs claimed to double stomach cancer risk
03 November, 2017The long-term use of proton pump inhibitors (PPIs), a class of drugs commonly used to treat acid reflux, has been linked by researchers to a highly increased risk in the development of stomach cancer.
Researchers map drug development trends
02 November, 2017G protein-coupled receptors (GPCR) are a target of around 40% drugs. A major mapping of these drugs by researchers has found that their pharmacological mechanisms are becoming more complex.
Why do Alzheimer's drugs work in the lab but not in patients?
31 October, 2017Japanese researchers have been investigating the reasons why so many trials of drugs for Alzheimer's disease fail, particularly after they have shown promise in the lab.
Aphria ships cannabis oil to Australia for pain management trial
24 October, 2017Canadian medical marijuana producer Aphria has completed its first shipment of cannabis oil to Australian medical life science company Medlab Clinical Limited.
76 new types of antibiotic resistance genes found
18 October, 2017Researchers have found 76 new types of antibiotic resistance genes by analysing large volumes of DNA data.
Clinical trials crucial to making new discoveries in cancer treatment
16 October, 2017Professor Tim Hughes and his team at the South Australian Health and Medical Research Institute have been at the forefront of research into chronic myeloid leukaemia (CML), leading many of the advancements in CML treatment over the last 20 years.
$16 million funding for Israeli-Australian biotech company
16 October, 2017Azura Ophthalmics has received US$16 million in Series B funding to develop treatments for meibomian gland dysfunction (MGD).
MedTech 2017 Annual Conference comes to Sydney next month
09 October, 2017The MedTech 2017 Annual Conference, hosted by the Medical Technology Association of Australia (MTAA), will take place from 1–2 November at Doltone House, Jones Bay Wharf, Sydney.
Biosensitive tattoos monitor glucose, hydration levels
05 October, 2017Researchers at Harvard and MIT have developed smart tattoo ink that changes colour if the wearer is dehydrated or if his/her blood sugar rises.
Novel drug combo for triple-negative breast cancer
03 October, 2017In the hunt for novel treatments against triple-negative breast cancer, US researchers have combined a new protein inhibitor with a chemotherapy drug.
Avita Medical and BARDA execute a US$24.3m contract option
22 September, 2017Regenerative medicine company Avita Medical has announced the execution of an expanded contract option valued at approximately US$24.3 million.
